American Association of Clinical Endocrinologists and American Diabetes Association Consensus Statement on Inpatient Glycemic Control
Open accessThe DOI matches its Crossref record; 166 of the 171 references it cites were found in a registry or an index.
Abstract
Does inpatient management of hyperglycemia represent a safety concern? 5. What systems need to be in place to achieve these recommendations?6.Is treatment of inpatient hyperglycemia cost-effective?7. What are the optimal strategies for transition to outpatient care? 8. What are areas for future research? QUESTION 1: DOES IMPROVING GLYCEMIC CONTROL IMPROVE CLINICAL OUTCOMES FOR INPATIENTS WITHHYPERGLYCEMIA? -Hyperglycemia in hospitalized patients, irrespective of its cause, is unequivocally associated with adverse outcomes (5,6,18 -25).Hyperglycemia occurs in patients with known or undiagnosed diabetes, or it occurs during acute illness in those with previously normal glucose tolerance (termed "stress hyperglycemia") (8,26).Intervention directed at reducing blood glucose (BG) levels has resulted in improved outcomes in some, but not all, studies (5,18 -25).Several recent clinical trials in critically ill patients have reported no reduction in mortality from intensive treatment targeting near-euglycemia versus conventional management targeting BG Ͻ180 mg/dl (Ͻ10.0 mmol/l).Of considerable concern are reports of harm, with higher rates of severe hypoglycemia and even increased mortality (14) resulting from intensive glycemic control (12)(13)(14)16,27,28).This variability in results may be attributable to several factors, including differences in intravenous (IV) insulin treatment protocols and their implementation, glycemic targets, patient populations, methods for glucose monitoring, and insulin adjustment (12,29).The following section focuses primarily on results of recent studies with an RCT design that investigated patient outcomes with protocols targeting nearnormalization of BG levels.Readers are referred to a previous ACE position statement (9), an ACE/ADA consensus statement (11), and a technical review (8) for details related to earlier studies supporting inpatient glycemic management.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Those without preexisting DM or stress hyperglycemia have a higher incidence of more postheart surgery complications.91,100–103”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [103]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredIn the citing paper
“Glucose targets >180 mg/dL or <110 mg/dL are no longer recommended in ICU patients.”
From A comparison study of continuous insulin infusion protocols in the medical intensive care unit: Computer-guided vs. Standard column-based algorithms (2010) · cites this paper as [25]
In the citing paper
“and the BG targets used in this study were lower than glycemic targets recently recommended by the AACE and ADA inpatient glycemic control task force.25”
From A comparison study of continuous insulin infusion protocols in the medical intensive care unit: Computer-guided vs. Standard column-based algorithms (2010) · cites this paper as [25]
In the citing paper
“Many guidelines that apply to hospitalized adults with hyperglycemia can probably be extrapolated to older adults130, 131.”
From Diabetes in Older Adults: A Consensus Report (2012) · cites this paper as [130]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Standards of Medical Care in Diabetes
Power, D. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,673
Intensive versus Conventional Glucose Control in Critically Ill Patients
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810625 · Cited by 5,119
Intensive insulin therapy in the medical ICU
Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P. J., Milants, I., Van Wijngaerden, E., Bobbaers, H., & Bouillon, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052521 · Cited by 3,639 · cited 4×
“Nevertheless, recent attempts to achieve tight glycemic control either have not reduced or have actually increased mortality in multicenter trials and clearly led to higher rates of hypoglycemia (13,14,16).”
BackgroundInfluentialIntensive insulin therapy and pentastarch resuscitation in severe sepsis
Brunkhorst, F. M., Engel, C., Bloos, F., Meier-Hellmann, A., Ragaller, M., Weiler, N., Moerer, O., Gruendling, M., Oppert, M., Grond, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa070716 · Cited by 2,921 · cited 5×
“The higher rates of severe hypoglycemia associated with intensive insulin therapy (12–14,16,27,28) raise the possibility that serious adverse events in the subgroup of patients experiencing hypoglycemia offset, at least in part, any benefit derived from strict glycemic control in the much larger subgroup of patients w…”
BackgroundInfluentialHyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes
Umpierrez, G. E., Isaacs, S. D., Bazargan, N., You, X., Thaler, L. M., & Kitabchi, A. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8341 · Cited by 2,195
Self-citationCapes, S. E., Hunt, D., Malmberg, K., & Gerstein, H. C. (2000) · The Lancet · doi:10.1016/s0140-6736(99)08415-9 · Cited by 2,187
Standards of Medical Care in Diabetes—2009
American Diabetes Association (2009) · Diabetes Care · doi:10.2337/dc09-s013 · Cited by 2,167
Bates, D. W. (1998) · JAMA · doi:10.1001/jama.280.15.1311 · Cited by 2,107
The Incidence and Severity of Adverse Events Affecting Patients after Discharge from the Hospital
Forster, A. J., Murff, H. J., Peterson, J. F., Gandhi, T. K., & Bates, D. W. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-3-200302040-00007 · Cited by 1,886 · cited 1×
“Medication errors and adverse drug events have been linked to poor communication of instructions to the patient at the time of discharge (156,157).”
Background
Research works printed but not linked: 5
- 28. Devos P, Preiser JC, Me ´lot C, et al. Im- pact of tight glucose control by intensive insulin therapy on ICU mortality and the rate of hypoglycaemia: final results of the GluControl study (Abstract). Intensive Care Med 2007;33:S189
- 87. Rodbard HW, Blonde L, Braithwaite SS, et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Endocr Pract 2007; 13(Suppl. 1):1-68
- 93. DiNardo M, Donihi AC, DeVita M, et al. A nurse directed protocol for recogni- tion and treatment of hypoglycemia in hospitalized patients. Pract Diabetol 2005;22:37-40
- 97. Donihi AC, Rea RS, Mihalko MA, et al. Comparison of different methods of transitioning MICU patients from intra- venous to subcutaneous insulin (Ab- stract). Diabetes 2007;57:A542
- 117. Reider J, Lin H, Dinardo M, et al. Efficacy of a guideline for treatment of corticoste- roid related hyperglycemia in the hospi- tal (Abstract). Diabetes 2008;57:A574 120.
Cited by
Items 301–400 of 1,001
Perioperative glycemic management in 2011: paradigm shifts
Maerz, L. L., & Akhtar, S. (2011) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e328348beb7 · Cited by 32
(2017) · The American Pharmacists Association eBooks · doi:10.21019/9781582122885.nationalclinicalguidelines · Cited by 32
Abdul-Ra’aoof, H. H., Tiryag, A. M., & Atiyah, M. A. (2024) · Academia Open · doi:10.21070/acopen.9.2024.8795 · Cited by 32
Compte, A. J. L., Pretty, C. G., Lin, J., Shaw, G. M., Lynn, A. M., & Chase, J. G. (2011) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2011.08.007 · Cited by 32
Inpatient Diabetes Management in the Twenty-First Century
Khazai, N. B., & Hamdy, O. (2016) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2016.06.013 · Cited by 33
Efficient and Accurate Hemorrhages Detection in Retinal Fundus Images Using Smart Window Features
Aziz, T., Ilesanmi, A. E., & Charoenlarpnopparut, C. (2021) · Applied Sciences · doi:10.3390/app11146391 · Cited by 32
“The American Diabetes Association (ADA) recommends that type 1 diabetes patients be screened three to five years after onset, and type 2 diabetic patients be screened one year after onset [5,6].”
BackgroundManagement of steroid-induced hyperglycemia in hospitalized patients with cancer: a review
Brady, V. J., Grimes, D., Armstrong, T., & LoBiondo-Wood, G. (2014) · Oncology nursing forum · doi:10.1188/14.onf.e355-e365 · Cited by 31
“Another point of interest for all of the studies was the definition of hyperglycemia as blood glucose greater than 180 mg/dl when, according to Moghissi et al. (2009), Smiley and Umpierrez (2010), and Umpierrez et al.”
BackgroundInfluentialWallia, A., Umpierrez, G. E., Nasraway, S. A., Klonoff, D. C., on behalf of PRIDE Investigators, Alexanian, S., Cagliero, E., Cook, C. B., Draznin, B., Drincic, A., et al. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816656380 · Cited by 29
Self-citationEarly Post-Renal Transplant Hyperglycemia
Iqbal, A., Zhou, K., Kashyap, S. R., & Lansang, M. C. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab697 · Cited by 32
Bellido, V., & Pérez, A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10225341 · Cited by 31
“The most effective way of reaching glucose targets is continuous intravenous infusion based on validated written or computerized protocols [72,73].”
MethodDombrowski, N. C., & Karounos, D. G. (2012) · Metabolism · doi:10.1016/j.metabol.2012.07.020 · Cited by 31
The extensive inpatient burden of diabetes and diabetes-related foot disease in Barbados
Taylor, C. G., Krimholtz, M., Belgrave, K. C., Hambleton, I. R., George, C., & Rayman, G. A. (2014) · Clinical Medicine · doi:10.7861/clinmedicine.14-4-367 · Cited by 31
Bernard, J. B., Munoz, C., Harper, J., Muriello, M., Rico, E., & Baldwin, D. (2011) · Journal of Hospital Medicine · doi:10.1002/jhm.866 · Cited by 29
“Current consensus guidelines from the American Diabetes Association and the American Association of Clinical Endocrinologists recommend the use of insulin-based treatment protocols for most hospitalized patients with hyperglycemia.(1) For non–critically ill patients, it is recommended to target a fasting blood glucose…”
BackgroundPieralli, F., Bazzini, C., Fabbri, A., Casati, C., Crociani, A., Corradi, F., Pignone, A. M., Morettini, A., & Nozzoli, C. (2015) · Internal and Emergency Medicine · doi:10.1007/s11739-015-1358-6 · Cited by 31
Mendez, C. E., Ata, A., Rourke, J. M., Stain, S. C., & Umpierrez, G. E. (2015) · Endocrine Practice · doi:10.4158/ep14577.or · Cited by 31
Self-citationThe impact of glycaemic variability on the surgical patient
Dhatariya, K., Levy, N., & Hall, G. (2016) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000000326 · Cited by 31
“1 mmol/l) should trigger a reassessment of antidiabetic therapy [2,67].”
BackgroundGu, W., Liu, Y., Chen, Y., Deng, W., Ran, X., Chen, L., Zhu, D., Yang, J., Shin, J., Lee, S. W., et al. (2017) · Diabetes & Metabolism · doi:10.1016/j.diabet.2016.12.009 · Cited by 31
Ferreira, L., Moniz, A. C., Carneiro, A. T. M., Miranda, A. S., Fangueiro, C., Fernandes, D., da Silva, I. C. B., Palhinhas, I., Lemos, J., Antunes, J. L. F., et al. (2018) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2018.08.028 · Cited by 31
Understanding Low Sugar from NICE-SUGAR
Hirsch, I. B. (2012) · New England Journal of Medicine · doi:10.1056/nejme1208208 · Cited by 31
Self-citationAnalytic evaluation of a new glucose meter system in 15 different critical care settings
Mitsios, J. V., Ashby, L. A., Haverstick, D. M., Bruns, D. E., & Scott, M. G. (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700518 · Cited by 30
Pichardo-Lowden, A., Umpierrez, G., Lehman, E. B., Bolton, M. D., DeFlitch, C. J., Chinchilli, V. M., & Haidet, P. M. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001557 · Cited by 30
Self-citationLo, C., Toyama, T., Oshima, M., Jun, M., Chin, K. L., Hawley, C. M., & Zoungas, S. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009966.pub3 · Cited by 30
Lanzillotta, C., Tramutola, A., Lanzillotta, S., Greco, V., Pagnotta, S. E., Sanchini, C., Angelantonio, S. D., Forte, E., Rinaldo, S., Paone, A., et al. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103221 · Cited by 30
“Diabetes mellitus has been diagnosed according to the American Diabetes Association 2009 criteria [42].”
Perioperative management of diabetes in elective patients: a region-wide audit
Jackson, M. J., Patvardhan, C., Wallace, F., Martin, A., Yusuff, H. O., Briggs, G., & Malik, R. A. (2016) · British Journal of Anaesthesia · doi:10.1093/bja/aev554 · Cited by 30
González, C. L., Atienza, E., Reyes-Umpierrez, D., Vellanki, P., Davis, G. M., Pasquel, F. J., Cardona, S., Fayfman, M., Peng, L., & Umpierrez, G. E. (2020) · Endocrine Practice · doi:10.4158/ep-2019-0481 · Cited by 30
Self-citationThe Queensland Inpatient Diabetes Survey (QuIDS) 2019: the bedside audit of practice
Donovan, P. J., Eccles‐Smith, J., Hinton, N., Cutmore, C., Porter, K., Abel, J., Allam, L., Dermedgoglou, A., & Puri, G. (2021) · The Medical Journal of Australia · doi:10.5694/mja2.51048 · Cited by 30
WENGER, N. K. (2011) · Clinical Cardiology · doi:10.1002/clc.20964 · Cited by 30
Effect Of A Targeted Glycemic Management Program On Provider Response To Inpatient Hyperglycemia
Donihi, A. C., Gibson, J. M., Noschese, M. L., DiNardo, M. M., Koerbel, G. L., Curll, M., & Korytkowski, M. T. (2011) · Endocrine Practice · doi:10.4158/ep10330.or · Cited by 30
Self-citationGlycemic control and outcome related to cardiopulmonary bypass
Thiessen, S., Vanhorebeek, I., & den Berghe, G. V. (2015) · Best practice & research. Clinical anaesthesiology · doi:10.1016/j.bpa.2015.03.003 · Cited by 30
Hiperglicemia por sepsis: del mecanismo a la clínica
Aleman, L., & Guerrero, J. (2018) · Revista médica de Chile · doi:10.4067/s0034-98872018000400502 · Cited by 30
Pérez, A., Reales, P., Barahona, M. J., Romero, M. G., Miñambres, I., & the HOSMIDIA Study Group (2014) · International Journal of Clinical Practice · doi:10.1111/ijcp.12498 · Cited by 30
Infección por coronavirus en pacientes con diabetes
Torres‐Tamayo, M., Caracas-Portilla, N., Peña-Aparicio, B., Juárez-Rojas, J. G., Medina-Urrutia, A. X., & Martínez-Alvarado, M. R. (2021) · Archivos de cardiología de México · doi:10.24875/acm.m20000068 · Cited by 29
Anderson, B. M., Wise, B. T., Joshi, M., Castillo, R., O'Toole, R. V., & Richards, J. E. (2021) · Journal of Orthopaedic Trauma · doi:10.1097/bot.0000000000002101 · Cited by 29
Hornum, M., Lindahl, J. P., von Zur‐Mühlen, B., Jenssen, T. G., & Feldt‐Rasmussen, B. (2013) · Transplant International · doi:10.1111/tri.12112 · Cited by 29
“During hospitalization, the Scandinavian Post-Transplant Diabetes Expert Group suggest that the treatment targets [89] should be:”
BackgroundMethodInfluentialOlveira, G., Tapia, M. J., Ocón, J., Cabrejas-Gómez, C., Ballesteros-Pomar, M. D., Vidal‐Casariego, A., Irigoyen, C. A., Olivares, J., Conde-García, M. C., García‐Manzanares, Á., et al. (2014) · Endocrine Practice · doi:10.4158/ep13441.or · Cited by 29
Anesthesia for Colorectal Surgery
Baldini, G., & Fawcett, W. J. (2015) · Anesthesiology Clinics · doi:10.1016/j.anclin.2014.11.007 · Cited by 29
Anesthetic Considerations on Adrenal Gland Surgery
Domi, R., Sula, H., Kaçi, M., Paparisto, S., Bodeci, A., & Xhemali, A. (2014) · Journal of Clinical Medicine Research · doi:10.14740/jocmr1960w · Cited by 29
“The goal is to maintain blood glucose levels within 120 - 180 mg/dL during the perioperative period [36].”
BackgroundClaudio Nazar, J., Echevarría, G. C., Lacassie, H. J., Flores, R. A., & Muñoz, H. R. (2011) · Revista médica de Chile · doi:10.4067/s0034-98872011000600009 · Cited by 29
Spat, S., Donsa, K., Beck, P., Höll, B., Mader, J. K., Schaupp, L. A., Augustin, T., Chiarugi, F., Lichtenegger, K. M., Plank, J., et al. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816676501 · Cited by 29
Stress Hyperglycemia as Predictive Factor of Recurrence in Children with Febrile Seizures
Costea, R. M., Maniu, I., Dobrotă, L., & Neamtu, B. M. (2020) · Brain Sciences · doi:10.3390/brainsci10030131 · Cited by 29
“According to the latest American Diabetes Association and American Association of Clinical Endocrinologists consensus, the definition on stress hyperglycemia implies any transient inpatient plasma glucose levels > 140 mg/dl (fasting plasma glucose of >126 mg/dl or random plasma glucose > 200 mg/dl) without evidence of…”
BackgroundAuzanneau, M., Fritsche, A., Icks, A., Siegel, E. G., Kilian, R., Karges, W., Lanzinger, S., & Holl, R. W. (2021) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.m2021.0151 · Cited by 28
Infección por coronavirus en pacientes con diabetes
Torres‐Tamayo, M., Caracas-Portilla, N., Peña-Aparicio, B., Juárez-Rojas, J. G., Medina-Urrutia, A. X., & Martínez-Alvarado, M. R. (2020) · Cardiovascular and Metabolic Science · doi:10.35366/93954 · Cited by 28
Rubin, D. J., & Golden, S. H. (2013) · Hospital Practice · doi:10.3810/hp.2013.02.1016 · Cited by 28
Oghazian, M. B., Javadi, M. R., Radfar, M., Torkamandi, H., Sadeghi, M., Hayatshahi, A., & Gholami, K. (2015) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1546 · Cited by 28
Rabinovich, M., Grahl, J., Durr, E. A., Gayed, R. M., Chester, K. W., McFarland, R., & McLean, B. A. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817747617 · Cited by 28
“A considerable amount of literature and evidence-based guidelines indicate that BG management in critically ill patients guided by protocol-driven intravenous (IV) insulin administration with predefined dosing adjustments leads to improved patient outcomes.(12-15) While most hospitals continue to utilize paper-based p…”
BackgroundMethodForlenza, G. P., Chinnakotla, S., Schwarzenberg, S. J., Cook, M. E., Radosevich, D. M., Manchester, C. S., Gupta, S., Nathan, B. M., & Bellin, M. D. (2014) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0061 · Cited by 28
Risk factors for hospital-acquired ‘poor glycemic control’: a case–control study
McHugh, M. D., Shang, J., Sloane, D. M., & Aiken, L. H. (2010) · International Journal for Quality in Health Care · doi:10.1093/intqhc/mzq067 · Cited by 28
Clemson University, C. E. S. (2006) · Oxford University Press eBooks · doi:10.1093/med/9780199543724.001.0001 · Cited by 28
Electronic Health Record–Based Decision-Making Support in Inpatient Diabetes Management
Gerwer, J. E., Bacani, G., Juang, P. S., & Kulasa, K. M. (2022) · Current Diabetes Reports · doi:10.1007/s11892-022-01481-0 · Cited by 27
Management of Post-Transplant Diabetes
Therasse, A., Wallia, A., & Molitch, M. E. (2012) · Current Diabetes Reports · doi:10.1007/s11892-012-0346-8 · Cited by 27
Fiorillo, C., Quero, G., Laterza, V., Mascagni, P., Longo, F., Menghi, R., Razionale, F., Rosa, F., Mezza, T., Boškoski, I., et al. (2019) · Surgery · doi:10.1016/j.surg.2019.11.006 · Cited by 27
Inpatient Hyperglycemia Management and COVID-19
Bellido, V., & Pérez, A. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00966-z · Cited by 27
“To achieve glycemic targets, continuous intravenous insulin infusion, based on validated written or computerized protocols, is the most effective method [7, 35, 36].”
MethodClinical Decision Support for Glycemic Management Reduces Hospital Length of Stay
Pichardo-Lowden, A. R., Haidet, P., Umpierrez, G. E., Lehman, E. B., Quigley, F. T., Wang, L., Rafferty, C. M., DeFlitch, C. J., & Chinchilli, V. M. (2022) · Diabetes Care · doi:10.2337/dc21-0829 · Cited by 28
Self-citationLiang, S., Tian, X., Gao, F., Man, M., Wang, Q., Li, J., Li, L., & Yang, Y. (2024) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-024-01293-0 · Cited by 27
“…Chen et al. defined stress hyperglycemia by other method (having a diabetes history or HbA1c ≥ 6.5%, and admission blood glucose ≥ 7.8 mmol/L) [26] instead of SHR, the results from their study and ours indicated that stress hyperglycemia may be more closely associated with adverse prognosis…”
ResultInfluentialPreoperative Optimization Strategies in Elective Spine Surgery
Daniels, A. H., Singh, M., Knebel, A., Thomson, C. G., Kuharski, M. J., Varona-Cocero, A. D., Nassar, J. E., Farias, M. J., & Diebo, B. G. (2025) · JBJS Reviews · doi:10.2106/jbjs.rvw.24.00210 · Cited by 27
Creating a Perioperative Glycemic Control Program
Alexanian, S. M., McDonnell, M. E., & Akhtar, S. (2011) · Anesthesiology Research and Practice · doi:10.1155/2011/465974 · Cited by 27
“Patients who would normally be transferred to the floor after a procedure should be assessed for transition to an appropriate hospital regimen, such as basal-bolus insulin [34].”
BackgroundControl glucémico en pacientes hospitalizados no críticos
Botella, M., Rubio, J. A., Percovich, J. C., Platero, E., Tasende, C., & Álvarez, J. (2011) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2011.07.011 · Cited by 27
Chen, E. B., Nooromid, M. J., Helenowski, I., Soper, N. J., & Halverson, A. L. (2019) · Surgery · doi:10.1016/j.surg.2019.04.043 · Cited by 27
Pasquel, F. J., Urrutia, M. A., Cardona, S., Zamudio-Coronado, K. W., Albury, B. S., Perez‐Guzman, M. C., Galindo, R. J., Chaudhuri, A., Iacobellis, G., Palacios, J. D., et al. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14347 · Cited by 27
Self-citationGerbaud, É., de la Poterie, A. B., Baudinet, T., Montaudon, M., Beauvieux, M.-C., Lemaître, A.-I., Cetran, L., Séguy, B., Picard, F., Vélayoudom, F.-L., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11061549 · Cited by 27
“Today, current guidelines concerning diabetes management of AHF patients [22] propose that insulin-based glycaemic control should be considered in cases of hyperglycaemia (>10 mmol/L or >180 mg/dL) with the target adapted to possible comorbidities.”
BackgroundA distributional reinforcement learning model for optimal glucose control after cardiac surgery
Desman, J. M., Hong, Z.-W., Sabounchi, M., Sawant, A. S., Gill, J., Costa, A. C., Kumar, G., Sharma, R., Gupta, A., McCarthy, P. J., et al. (2025) · npj Digital Medicine · doi:10.1038/s41746-025-01709-9 · Cited by 26
“To achieve this target, most cardiac surgery centers employ institutional protocols for managing hyperglycemia 15,36 – 38 .”
Chen, Y., Zhang, H., Hou, X., Li, X., Qian, X., Feng, X., Liu, S., Shi, N., Zhao, W., Hu, S., et al. (2020) · Journal of Diabetes · doi:10.1111/1753-0407.13108 · Cited by 26
“0 mmol/L.(13,14) However, the evidence is limited on the appropriateness of using the same glucose target for hyperglycemic patients with and without a history of diabetes.”
BackgroundMethodMorse, J. L., Gay, W., Korwek, K. M., McLean, L. E., Poland, R. E., Guy, J. S., Sands, K., & Perlin, J. B. (2021) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.291 · Cited by 26
Clinical challenges of glycemic control in the intensive care unit: A narrative review
Sreedharan, R., Martini, A., Das, G., Aftab, N., Khanna, S. K., & Ruetzler, K. (2022) · World Journal of Clinical Cases · doi:10.12998/wjcc.v10.i31.11260 · Cited by 26
Combes, J., Borot, S., Mougel, F., & Penfornis, A. (2010) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01311.x · Cited by 26
“122 Combes et al. Volume 13 No. 2 February 2011 DIABETES, OBESITY AND METABOLISM review article In light of the NICE-SUGAR data, the American Diabetes Association (ADA) and American Association of Clinical Endocrinologists (AACE) [77] recently revised their guidelines on inpatient glycaemic control.”
BackgroundCarbajo, M. A., Jiménez, J. M., Castro, M. J., Ortiz-Solórzano, J., & Arango, A. (2014) · PubMed · doi:10.3305/nh.2014.30.5.7720 · Cited by 27
Maynard, G. A., Childers, D., Holdych, J., Kendall, H. E., Hoag, T., & Harrison, K. (2017) · The Joint Commission Journal on Quality and Patient Safety · doi:10.1016/j.jcjq.2017.01.003 · Cited by 26
The case for supporting inpatient glycemic control programs now: The evidence and beyond
Braithwaite, S. S., Magee, M. F., Sharretts, J. M., Schnipper, J. L., Amin, A., & Maynard, G. A. (2008) · Journal of Hospital Medicine · doi:10.1002/jhm.350 · Cited by 26
Failure After Laparoscopic Pyeloplasty: Prevention and Management
Tan, H.-J., Ye, Z., Roberts, W. W., & Wolf, J. S. (2011) · Journal of Endourology · doi:10.1089/end.2010.0647 · Cited by 26
“27 Repair of UPJO may be more technically challenging in the salvage setting because of fibrosis and inflammation.”
Olveira, G., Tapia, M. J., Ocón, J., Cabrejas-Gómez, C., Ballesteros-Pomar, M. D., Vidal‐Casariego, A., Irigoyen, C. A., Olivares, J., Conde-García, M. D. C., García‐Manzanares, Á., et al. (2014) · Nutrition · doi:10.1016/j.nut.2014.04.023 · Cited by 26
Hyperglycemia management in patients with posttransplantation diabetes
Galindo, R. J., Fried, M., Breen, T., & Tamler, R. (2016) · Endocrine Practice · doi:10.4158/ep151039.ra · Cited by 25
Advances in the management of hyperglycaemia and diabetes mellitus during hospitalization
Idrees, T., Castro-Revoredo, I., Dhatariya, K., Hernandez, L., & Umpierrez, G. E. (2025) · Nature Reviews Endocrinology · doi:10.1038/s41574-025-01157-1 · Cited by 25
“…individuals, the American Association of Clinical Endocrinology guidelines for the management of hyperglycaemia in the non-critical care setting recommend a target level of glucose in the blood of 7.8 mmol/l (140 mg/dl) for fasting and 10.0 mmol/l (180 mg/dl) for random blood glucose values 26 .”
InfluentialSelf-citationInteractive Web-Based Learning
Rider, B. B., Lier, S. C., Johnson, T., & Hu, D. J. (2015) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2015.07.038 · Cited by 25
Guidelines for Stroke Survivors With Diabetes Mellitus
Gaillard, T. R., & Miller, E. (2018) · Stroke · doi:10.1161/strokeaha.118.020745 · Cited by 25
Inpatient hypoglycaemia: understanding who is at risk
Ruan, Y., Moysova, Z., Tan, G. D., Lumb, A. N., Davies, J., & Rea, R. D. (2020) · Diabetologia · doi:10.1007/s00125-020-05139-y · Cited by 25
Pilot trial of diabetes self-management education in the hospital setting
Korytkowski, M. T., Koerbel, G. L., Kotagal, L. V., Donihi, A. C., & DiNardo, M. M. (2014) · Primary care diabetes · doi:10.1016/j.pcd.2013.11.008 · Cited by 25
“This resulted in recruitment of only a small number of patients who were recruited in each group, despite a high prevalence of diabetes among the inpatient population [27,28].”
BackgroundSelf-citationPerceptions, Barriers, and Knowledge of Inpatient Glycemic Control: A Survey of Health Care Workers
Beliard, R. C., Muzykovsky, K., Vincent, W. R., Shah, B. K., & Davanos, E. (2015) · Journal of Pharmacy Practice · doi:10.1177/0897190014566309 · Cited by 25
“Despite recent updates to the AACE/ADA Consensus Statement, response to reform current clinical practices to reflect recent literature has been slow and often meets resistance possibly due to systematic and perceived barriers.(1) There have been numerous publications emphasizing the importance of focusing on hyperglyc…”
BackgroundMethodResultInfluentialThe association between glycemic control and clinical outcomes after kidney transplantation
Ramirez, S. C., Maaske, J., Kim, Y., Neagu, V., DeLange, S., Mazhari, A., Gao, W., Emanuele, M. A., Emanuele, N., Baldwin, D., et al. (2014) · Endocrine Practice · doi:10.4158/ep13463.or · Cited by 24
Multifaceted approach to reducing occurrence of severe hypoglycemia in a large healthcare system
Milligan, P. E., Bocox, M. C., Pratt, E., Hoehner, C. M., Krettek, J. E., & Dunagan, W. C. (2015) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp150077 · Cited by 24
Patient Self-Management of Diabetes Care in the Inpatient Setting: Pro
Mabrey, M. E., & Setji, T. L. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815590827 · Cited by 24
Talaverón, J. M. L., Leiva, E., Antonio, J. M.-D., Berlana, D., Badia, M., Casasín, T., Miana, M., Pons, M., Maroto, M. P., Chicharro, L., et al. (2012) · PubMed · doi:10.3305/nh.2012.27.5.5880 · Cited by 24
Implementation of the Glucommander Method of Adjusting Insulin Infusions in Critically Ill Patients
Yamashita, S. K., Ng, E., Brommecker, F., Silverberg, J., & Adhikari, N. K. J. (2011) · The Canadian Journal of Hospital Pharmacy · doi:10.4212/cjhp.v64i5.1068 · Cited by 24
Glucose control in non‐critically ill inpatients with diabetes: towards closed‐loop
Thabit, H., & Hovorka, R. (2013) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12228 · Cited by 24
“Several intravenous insulin infusion protocols are currently being utilized by various institutions [50].”
BackgroundMulla, I., Schmidt, K., Cashy, J., Wallia, A., Andrei, A., Oakes, D. J., Aleppo, G., Li, C., Grady, K. L., McGee, E. C., et al. (2014) · Diabetes Care · doi:10.2337/dc14-1199 · Cited by 24
Oliveira, R. A., Mancero, J. M. P., Faria, D. F., & Poveda, V. D. B. (2019) · Progress in Transplantation · doi:10.1177/1526924819835831 · Cited by 24
“However, other targets for glucose maintenance have been suggested: 150 to 200 mg/dL by the World Health Organization,(15) 150 mg/dL by Paka et al,(16) and 140 to 180 mg/dL in the guideline proposed by the American Association of Clinical Endocrinologists and the American Diabetes Association.(17) A review of the lite…”
Influence of Hyperglycemia Associated with Enteral Nutrition on Mortality in Patients with Stroke
Gómez, J. J. L., Delgado-García, E., Coto-García, C., Torres-Torres, B., Hoyos, E. G., Valles, C. S., Castro-Lozano, Á., Arenillas, J. F., & de Luis, D. A. (2019) · Nutrients · doi:10.3390/nu11050996 · Cited by 24
Intensive Glycemic Control in Cardiac Surgery
Tsai, L. L., Jensen, H., & Thourani, V. H. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0719-5 · Cited by 25
“Under this guideline, they suggest that more strict goals of 110 to 140 mg/dL may be appropriate for some patients [46].”
BackgroundPreoperative patient assessment: Identifying patients at high risk
Boehm, O., Baumgarten, G., & Hoeft, A. (2016) · Best practice & research. Clinical anaesthesiology · doi:10.1016/j.bpa.2016.04.005 · Cited by 24
Park, S. J., Oh, A. R., Lee, J., Yang, K., & Park, J. (2024) · Korean Journal of Anesthesiology · doi:10.4097/kja.23301 · Cited by 26
“Although some current guidelines recommend perioperative glycemic control [14,24,25], no treatment strategy has been optimized [7].”
BackgroundMethodTrends in glycemic control over a 2‐year period in 126 US hospitals
Bersoux, S., Cook, C. B., Kongable, G. L., & Shu, J. (2012) · Journal of Hospital Medicine · doi:10.1002/jhm.1997 · Cited by 23
Garcia, C., Wallia, A., Gupta, S., Schmidt, K., Malekar‐Raikar, S., Oakes, D. J., Aleppo, G., Grady, K., McGee, E. C., Cotts, W., et al. (2013) · Clinical Transplantation · doi:10.1111/ctr.12118 · Cited by 23
“Black 16 (17) 2 (8) 14 (21) NS Asian 4 (4) 2 (8) 2 (3) NS Hispanic 4 (4) 0 (0) 4 (6) NS Other 1 (1) 0 (0) 1 (2) Cardiac indication for transplant Ischemic CM 35 (38) 13 (50) 22 (33) NS Dilated CM 23 (25) 4 (15) 19 (73) NS Non-ischemic CM 9 (10) 3 (12) 6 (9) NS”
BackgroundResultInfluentialWang, G., Liu, J., Yang, N., Gao, X., Fan, H. J., Xu, Y., & Yang, W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105698 · Cited by 23
“As the classical hypoglycemic drugs [3], acarbose and metformin have lower cost, and long-term safety has been confirmed in more than hundreds of studies [4–5].”
BackgroundZhu, C., Chen, J., Pan, J., Qiu, Z., & Xu, T. (2018) · Medicine · doi:10.1097/md.0000000000011671 · Cited by 23
Attri, B., Goyal, A., Gupta, Y., & Tandon, N. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00873-3 · Cited by 23
“Typically, the TDD is calculated as 80% of the total daily insulin requirement on intravenous infusion in the last 24–48 h [9].”
BackgroundShogbon, A. O., Ngo, D., Jacob, B., Kimble, L. P., & Ryan, G. J. (2014) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0072 · Cited by 23
Managing hyperglycemia and diabetes in patients receiving enteral feedings: A health system approach
Mabrey, M., Barton, A. B., Corsino, L., Freeman, S. B., Davis, E. D., Bell, E. L., & Setji, T. L. (2015) · Hospital Practice · doi:10.1080/21548331.2015.1022493 · Cited by 23
“Over the past two decades, the management of hyperglycemia and diabetes in the inpatient setting has been the focus of many studies and recommendations [1-10].”
BackgroundEffect of Case-Based Training for Medical Residents on Inpatient Glycemia
Tamler, R., Green, D. E., Skamagas, M., Breen, T. L., Looker, H. C., Babyatsky, M. W., & LeRoith, D. (2011) · Diabetes Care · doi:10.2337/dc11-0517 · Cited by 23
“Nonadherence to published guidelines (3), inadequate hypoglycemia precautions, delayed titration of insulin, and regular insulin sliding-scale use are widely prevalent practices associated with worse dysglycemia (4,5).”
BackgroundManagement of insulin pump therapy in children with type 1 diabetes
Abdullah, N., Pesterfield, C., Elleri, D., & Dunger, D. B. (2014) · Archives of Disease in Childhood Education & Practice · doi:10.1136/archdischild-2013-304501 · Cited by 23
Protecting the brain during neurosurgical procedures: strategies that can work
Beheiry, H. E. (2012) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0b013e3283579622 · Cited by 23
“Consequently, the American Diabetes Association and the American Association of Clinical Endocrinologists [39] set an upper limit of 10 mmol/l at which insulin therapy should be started.”
BackgroundInsulin Therapy in the Elderly Patient With Diabetes
Tanwani, L. K. (2011) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2011.02.006 · Cited by 23
Metadata
- Authors
- Moghissi, E. S., Korytkowski, M. T., DiNardo, M., Einhorn, D., Hellman, R., Hirsch, I. B., Inzucchi, S. E., Ismail-Beigi, F., Kirkman, M. S., & Umpierrez, G. E.
- Affiliations
- University of California, Los Angeles (US)
- University of Pittsburgh (US)
- University of California San Diego (US)
- University of Missouri–Kansas City (US)
- University of Washington (US)
- Yale New Haven Hospital (US)
- Department of Medicine, Physiology and Biophysics, Division of Clinical and Molecular Endocrinology, Case Western Reserve University, Cleveland, Ohio;
- American Diabetes Association (US)
- Emory University (US)
- Corresponding author
- Moghissi, Etie S.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-06-01
- Volume
- 32
- Issue
- 6
- Pages
- 1119-1131
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2681039
- OpenAlex
- W2149347361
- Cited by
- 1,444
- References
- 171
- Citations by year
- 2026: 23 · 2025: 48 · 2024: 78 · 2023: 63 · 2022: 66 · 2021: 83 · 2020: 98 · 2019: 67 · 2018: 84 · 2017: 85 · 2016: 101 · 2015: 105 · 2014: 134 · 2013: 89 · 2012: 131
- FWCI
- 76.48
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- inpatient glycemic control, hyperglycemia, stress hyperglycemia, intensive insulin therapy, hypoglycemia, critically ill patients, hospitalized patients, transition to outpatient care, cost-effectiveness, glucose monitoring, clinical outcomes
- MeSH terms
- Blood Glucose, Consensus Statements as Topic, Diabetes Mellitus, Endocrinology, Humans, Hyperglycemia, Inpatients, Societies, Medical
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.